Register entry

KITE PHARMA, INC.

Data as of · How to read this entry

Registered sites
5
Active NDC listings
3
Live patents
0
Countries
2
Base
United States
Authorisation

Registered operations

Analytical testing5Active ingredient (API) manufacture1Labelling3Finished drug manufacture2Packaging3
Sites

Registered establishments

5
EstablishmentAddressRegistered forFEI / DUNS
Kite Pharma EU B.V.Registrant: KITE PHARMA, INC.Tufsteen 1, Hoofddorp, NT 2132, Netherlands (NLD)Analytical testing, Labelling, Packaging3018906348491405777
KITE PHARMA, INC.2355 UTAH AVE, EL SEGUNDO, California (CA) 90245, United States (USA)Analytical testing, Labelling, Finished drug manufacture, Packaging3012583739080315797
Kite Pharma, Inc.Registrant: KITE PHARMA, INC.9021 Bennett Creek Blvd, Frederick, Maryland (MD) 21704, United States (USA)Analytical testing, Labelling, Finished drug manufacture, Packaging3016888173117989834
Gilead Sciences, Inc.Registrant: KITE PHARMA, INC.4010 Ocean Ranch Blvd, Oceanside, California (CA) 92056, United States (USA)Analytical testing, Active ingredient (API) manufacture3012871330117649816
Kite Pharma, Inc.Registrant: KITE PHARMA, INC.1800 Stewart St., Santa Monica, California (CA) 90404, United States (USA)Analytical testing3014007584116931311
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 cellular therapy. By marketing category: BLA 3.

Dosage formNDCs
suspension3
RouteNDCs
intravenous3
Labeller name on the listingNDCs
kite pharma, inc.3
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
TECARTUSbrexucabtagene autoleucelsuspension, intravenous71287-219BLA
TECARTUSbrexucabtagene autoleucelsuspension, intravenous71287-220BLA
YESCARTAaxicabtagene ciloleucelsuspension, intravenous71287-119BLA
Neighbours

Registered in the same town

6
Compare

Comparable companies in United States

Enquiry

Common questions

Is KITE PHARMA, INC. FDA approved?
KITE PHARMA, INC. holds 5 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are KITE PHARMA, INC.'s drugs manufactured?
At registered sites in the Netherlands, the United States. The FDA register lists Hoofddorp; EL SEGUNDO, CA; Frederick, MD; Oceanside, CA; Santa Monica, CA. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
What drugs does KITE PHARMA, INC. make?
3 products are listed under KITE PHARMA, INC. in the openFDA NDC Directory, most often as suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.